Q3 2024 |
121 |
$1.72B |
+$420M |
-$227M |
+$193M |
HPQ, CSCO, GOLD, AMT, EXC
|
13F-HR |
10/31/2024, 09:02 AM |
Q2 2024 |
102 |
$1.42B |
+$137M |
-$310M |
-$173M |
HPQ, CSCO, GOLD, GFI, AMT
|
13F-HR |
8/1/2024, 04:46 PM |
Q1 2024 |
111 |
$1.59B |
+$232M |
-$291M |
-$59M |
HPQ, QCOM, CSCO, GOLD, GFI
|
13F-HR |
5/8/2024, 09:14 AM |
Q4 2023 |
103 |
$1.65B |
+$162M |
-$216M |
-$53.8M |
HPQ, QCOM, CSCO, PDD, GOLD
|
13F-HR |
2/5/2024, 08:42 AM |
Q3 2023 |
131 |
$1.53B |
+$154M |
-$564M |
-$410M |
HPQ, CSCO, QCOM, GOLD, PDD
|
13F-HR |
10/26/2023, 08:30 AM |
Q2 2023 |
127 |
$2.06B |
+$264M |
-$1.54B |
-$1.28B |
HPQ, CSCO, NEM, GOLD, QCOM
|
13F-HR |
8/4/2023, 10:35 AM |
Q1 2023 |
128 |
$3.24B |
+$304M |
-$320M |
-$15.9M |
HPQ, MSFT, ELV, TSM, NEM
|
13F-HR |
5/15/2023, 09:10 AM |
Q4 2022 |
129 |
$3.19B |
+$230M |
-$313M |
-$83.8M |
ELV, SCHW, HPQ, MSFT, CSX
|
13F-HR |
1/31/2023, 05:24 PM |
Q3 2022 |
130 |
$2.97B |
+$197M |
-$211M |
-$14.3M |
ELV, HPQ, KR, SCHW, MSFT
|
13F-HR |
11/14/2022, 09:00 AM |
Q2 2022 |
128 |
$3.19B |
+$463M |
-$137M |
+$326M |
HPQ, KR, NEM, MSFT, ELV
|
13F-HR |
8/9/2022, 08:28 AM |
Q1 2022 |
134 |
$3.6B |
+$466M |
-$405M |
+$60.8M |
HPQ, NEM, TSM, KR, AMZN
|
13F-HR |
5/13/2022, 11:45 AM |
Q4 2021 |
125 |
$3.61B |
+$192M |
-$110M |
+$82.1M |
HPQ, MSFT, AMZN, ELV, KR
|
13F-HR |
2/14/2022, 02:39 PM |
Q3 2021 |
118 |
$3.27B |
+$125M |
-$212M |
-$86.8M |
AMZN, HPQ, CHTR, MSFT, KR
|
13F-HR |
11/3/2021, 11:15 AM |
Q2 2021 |
134 |
$3.5B |
+$484M |
-$369M |
+$115M |
HPQ, AMZN, NEM, TSM, CHTR
|
13F-HR |
8/2/2021, 04:57 PM |
Q1 2021 |
126 |
$3.3B |
+$337M |
-$291M |
+$45.9M |
HPQ, AMZN, TSM, NEM, LAZ
|
13F-HR |
5/17/2021, 12:11 PM |
Q4 2020 |
122 |
$3B |
+$587M |
-$442M |
+$145M |
AMZN, TSM, HPQ, NEM, LAZ
|
13F-HR |
2/8/2021, 03:18 PM |
Q3 2020 |
107 |
$2.49B |
+$302M |
-$230M |
+$72.2M |
AMZN, NEM, GOLD, TSM, CHTR
|
13F-HR |
11/12/2020, 08:09 AM |
Q2 2020 |
110 |
$2.2B |
+$245M |
-$497M |
-$252M |
AMZN, NEM, GOLD, KR, CHTR
|
13F-HR |
8/4/2020, 08:41 AM |
Q1 2020 |
111 |
$1.97B |
+$225M |
-$254M |
-$28.1M |
AMZN, NEM, GOLD, KR, CHTR
|
13F-HR |
5/6/2020, 09:24 AM |
Q4 2019 |
114 |
$2.47B |
+$172M |
-$238M |
-$66.2M |
AMZN, NEM, GOLD, LAZ, AAL
|
13F-HR |
2/11/2020, 08:54 AM |
Q3 2019 |
124 |
$2.35B |
+$327M |
-$198M |
+$128M |
AMZN, GOLD, NEM, MCK, LAZ
|
13F-HR |
11/12/2019, 08:55 AM |
Q2 2019 |
121 |
$2.28B |
+$277M |
-$304M |
-$27M |
AMZN, AAL, CSX, HBAN, BID
|
13F-HR |
8/13/2019, 09:18 AM |
Q1 2019 |
113 |
$2.19B |
+$275M |
-$219M |
+$56.4M |
AMZN, CSX, AAL, KR, HBAN
|
Restatement |
5/15/2019, 02:54 PM |
Q4 2018 |
106 |
$1.93B |
+$466M |
-$435M |
+$30.5M |
AMZN, AAL, KR, CSX, HBAN
|
Restatement |
2/14/2019, 05:16 PM |
Q3 2018 |
124 |
$2.2B |
+$403M |
-$298M |
+$105M |
AMZN, CSX, AAL, KR, HBAN
|
Restatement |
4/29/2019, 03:13 PM |
Q2 2018 |
125 |
$1.99B |
+$365M |
-$270M |
+$94.9M |
AMZN, CSX, KR, AAL, HBAN
|
Restatement |
4/29/2019, 03:09 PM |
Q1 2018 |
132 |
$1.9B |
+$360M |
-$427M |
-$66.2M |
AAL, AMZN, CSX, HBAN, KR
|
Restatement |
4/29/2019, 03:04 PM |
Q4 2017 |
132 |
$1.95B |
+$352M |
-$292M |
+$60.3M |
AMZN, AAL, CSX, KR, MSFT
|
Restatement |
4/29/2019, 02:52 PM |
Q3 2017 |
127 |
$1.79B |
+$344M |
-$338M |
+$6.03M |
AMZN, MSFT, CSX, AAL, JNJ
|
Restatement |
4/29/2019, 02:46 PM |
Q2 2017 |
134 |
$1.73B |
+$314M |
-$343M |
-$28.9M |
AMZN, JNJ, MSFT, CSX, AAL
|
Restatement |
4/29/2019, 02:37 PM |
Q1 2017 |
135 |
$1.71B |
+$438M |
-$460M |
-$21.2M |
AMZN, JNJ, MSFT, PFE, MRK
|
Restatement |
4/29/2019, 02:28 PM |
Q4 2016 |
138 |
$1.64B |
+$318M |
-$319M |
-$733K |
MSFT, JNJ, MRK, PFE, LLY
|
Restatement |
4/29/2019, 02:22 PM |
Q4 2016 |
140 |
$1.53B |
+$300M |
-$410M |
-$110M |
MSFT, JNJ, MRK, PFE, LLY
|
Restatement |
2/13/2017, 11:21 AM |
Q3 2016 |
142 |
$1.63B |
+$345M |
-$356M |
-$11M |
MSFT, MRK, JNJ, AMZN, LLY
|
Restatement |
4/29/2019, 02:12 PM |
Q3 2016 |
144 |
$1.58B |
+$354M |
-$414M |
-$59.3M |
MSFT, MRK, JNJ, AMZN, LLY
|
Restatement |
11/22/2016, 12:27 PM |
Q2 2016 |
137 |
$1.57B |
+$492M |
-$336M |
+$156M |
JNJ, MRK, PFE, MSFT, LLY
|
Restatement |
4/29/2019, 02:07 PM |
Q1 2016 |
140 |
$1.38B |
+$393M |
-$467M |
-$74.1M |
MSFT, MRK, JNJ, PFE, LLY
|
Restatement |
4/29/2019, 02:00 PM |
Q4 2015 |
143 |
$1.47B |
+$493M |
-$359M |
+$134M |
MSFT, LLY, MRK, PFE, JNJ
|
Restatement |
4/29/2019, 01:55 PM |
Q3 2015 |
138 |
$1.26B |
+$393M |
-$312M |
+$81.3M |
LLY, PFE, MSFT, AMZN, MRK
|
Restatement |
4/29/2019, 01:27 PM |
Q2 2015 |
141 |
$1.21B |
+$357M |
-$379M |
-$22M |
PFE, MRK, LLY, MSFT, JNJ
|
Restatement |
4/29/2019, 01:11 PM |
Q1 2015 |
147 |
$1.23B |
+$371M |
-$430M |
-$59M |
PFE, LLY, MRK, JNJ, MSFT
|
Restatement |
4/29/2019, 01:04 PM |
Q1 2015 |
148 |
$1.18B |
+$347M |
-$474M |
-$127M |
PFE, LLY, MRK, JNJ, MSFT
|
Restatement |
6/3/2015, 10:32 AM |
Q4 2014 |
154 |
$1.3B |
+$456M |
-$232M |
+$224M |
LLY, PFE, MRK, MSFT, JNJ
|
Restatement |
4/29/2019, 12:55 PM |
Q3 2014 |
144 |
$1.02B |
+$302M |
-$389M |
-$87.1M |
LLY, MRK, PFE, MSFT, JNJ
|
Restatement |
4/29/2019, 12:47 PM |
Q2 2014 |
135 |
$1.12B |
+$415M |
-$440M |
-$24.4M |
MRK, LLY, PFE, MSFT, JNJ
|
Restatement |
4/29/2019, 12:37 PM |
Q1 2014 |
150 |
$1.13B |
+$415M |
-$263M |
+$153M |
PFE, MRK, LLY, MSFT, JNJ
|
13F-HR |
5/14/2014, 02:58 PM |
Q4 2013 |
143 |
$943M |
$0 |
$0 |
|
PFE, MRK, LLY, JNJ, MSFT
|
13F-HR |
2/13/2014, 12:55 PM |